hu1418K322A + Temozolomide + Irinotecan clinical trials

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

This study is testing a new treatment called hu14.18K322A, given with chemotherapy, for children and young people with a type of cancer called high-risk neuroblastoma. It aims to see if this combination treatment is safe and effective in fighting the cancer.